TFOS DEWS II management and therapy report
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …
based review of current dry eye therapies and management options. Management options …
Artificial tears potpourri: a literature review
M Moshirfar, K Pierson, K Hanamaikai… - Clinical …, 2014 - Taylor & Francis
Numerous brands and types of artificial tears are available on the market for the treatment of
dysfunctional tear syndrome. Past literature has focused on comparing the components of …
dysfunctional tear syndrome. Past literature has focused on comparing the components of …
[PDF][PDF] Management of dry eye disease
MA Lemp - Am J Manag Care, 2008 - ajmc.s3.amazonaws.com
The management of dry eye disease (DED) encompasses both pharmacologic and
nonpharmacologic approaches, including avoidance of exacerbating factors, eyelid …
nonpharmacologic approaches, including avoidance of exacerbating factors, eyelid …
Systane® lubricant eye drops in the management of ocular dryness
U Benelli - Clinical Ophthalmology, 2011 - Taylor & Francis
The understanding of dry eye disease has advanced recently through increasing recognition
that the etiology of the condition involves both tear evaporation and insufficient tear …
that the etiology of the condition involves both tear evaporation and insufficient tear …
Treatment of chronic dry eye: focus on cyclosporine
GD Kymionis, DI Bouzoukis, VF Diakonis… - Clinical …, 2008 - Taylor & Francis
To review the current treatment of chronic dry eye syndrome, focusing on cyclosporine A
(CsA), a systematic literature search was performed using PubMed databases in two steps …
(CsA), a systematic literature search was performed using PubMed databases in two steps …
[HTML][HTML] Sulfated chitosan as tear substitute with no antimicrobial activity
Chitosan of high molar mass and with 82% deacetylation was sulfated using two procedures
and characterized. In the first method sample chitosan-S1 was produced using …
and characterized. In the first method sample chitosan-S1 was produced using …
An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops
GW Ousler, C Michaelson, MT Christensen - Cornea, 2007 - journals.lww.com
Purpose: To report the performance of an artificial tear containing propylene glycol and
polyethylene glycol as active demulcents with hydroxypropyl-guar as a gelling agent …
polyethylene glycol as active demulcents with hydroxypropyl-guar as a gelling agent …
Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation
WF Davitt, M Bloomenstein, M Christensen… - Journal of ocular …, 2010 - liebertpub.com
Purpose: The effective management of dry eye must include a clinically meaningful
reduction in ocular staining. Evaluations of corneal and conjunctival staining and other …
reduction in ocular staining. Evaluations of corneal and conjunctival staining and other …
Symptom relief following a single dose of propylene glycol-hydroxypropyl guar nanoemulsion in patients with dry eye disease: a phase IV, multicenter trial
S Silverstein, E Yeu, J Tauber, M Guillon… - Clinical …, 2020 - Taylor & Francis
Purpose To evaluate symptom relief in patients with dry eye disease (DED) following a
single drop of propylene glycol-hydroxypropyl guar (PG-HPG) nanoemulsion (Systane® …
single drop of propylene glycol-hydroxypropyl guar (PG-HPG) nanoemulsion (Systane® …
Efficacy and safety of phospholipid nanoemulsion-based ocular lubricant for the management of various subtypes of dry eye disease: a phase IV, multicenter trial
E Yeu, S Silverstein, M Guillon, MM Schulze… - Clinical …, 2020 - Taylor & Francis
Purpose To evaluate the clinical efficacy and safety of propylene glycol/hydroxypropyl-guar
(PG-HPG)-based nanoemulsion (Systane® Complete) lubricant eye drops in participants …
(PG-HPG)-based nanoemulsion (Systane® Complete) lubricant eye drops in participants …